Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04279535 · ClinicalTrials.gov registry record · Early Phase 1
Topical Vitamin C for Treatment of Basal Cell Cancer
A Early Phase 1 study, sponsored by Center for Biomedical Research.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 25
- Enrollment target
NCT04279535: Completed Early Phase 1 study, sponsored by Center for Biomedical Research.
NCT04279535 is a Early Phase 1 study that has completed, run by Center for Biomedical Research. The registered enrollment target is 25 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04279535, a Early Phase 1 study, has completed, sponsored by Center for Biomedical Research.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
Randomized coomparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment biopsy proven basal cell carcinomas inotherwise healthy adult patients. Outcome measure was biopsy proven resolution of the carcinoma.
Primary Outcome
Number of lesions resolved out of total of 6 treated.
Interventions
- DRUG Topical Ascorbic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2019-06-01 |
| Phase | Early Phase 1 |
What the finished NCT04279535 record still lists
NCT04279535 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 1 intervention - of which Topical Ascorbic Acid is the first listed.
NCT04279535 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04279535 about?
NCT04279535 is a clinical study titled "Topical Vitamin C for Treatment of Basal Cell Cancer". Randomized coomparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment biopsy proven basal cell carcinomas inotherwise healthy adult patients. Outcome measure was biopsy proven resolution of the carci...
What is the current status of trial NCT04279535?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 25 participants. The study started on 2018-03-01. Estimated completion is 2019-06-01.
What interventions are being tested in trial NCT04279535?
The interventions under investigation include: Topical Ascorbic Acid (DRUG).
Who is sponsoring clinical trial NCT04279535?
This trial is sponsored by Center for Biomedical Research, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04279535's enrollment target sits among peer trials
25 1000th of 2000 higher than 964 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI